BIOMARKERS: GDF-15 and risk stratification in atrial fibrillation

    loading  Checking for direct PDF access through Ovid

Abstract

Biomarkers are needed to accurately represent or predict clinical outcomes for optimal management of patients with atrial fibrillation (AF) in clinical practice. Growth differentiation factor-15, a member of the transforming growth factor-β family, has an independent prognostic role for major bleeding and death in patients with AF receiving oral anticoagulation.

Related Topics

    loading  Loading Related Articles